BURSTA US panel’s decision not to recommend the preservative thiomersal won’t affect vaccine availability in Australia, say experts. But it will stoke dangerous anti-vax sentiment
Get our breaking news email, free app or daily news podcast
An influential US vaccine panel has recommended against seasonal influenza vaccines containing a specific preservative, causing concern among medical and scientific experts who fear the decision may impact future vaccine availability.
But what is the preservative, why is it the subject of controversy and will it affect vaccines in Australia?
Continue reading...